KR920009735B1 - 단순 헤르페스 바이러스 서브유니트 왁진의 제조방법 - Google Patents

단순 헤르페스 바이러스 서브유니트 왁진의 제조방법 Download PDF

Info

Publication number
KR920009735B1
KR920009735B1 KR1019850006051A KR850006051A KR920009735B1 KR 920009735 B1 KR920009735 B1 KR 920009735B1 KR 1019850006051 A KR1019850006051 A KR 1019850006051A KR 850006051 A KR850006051 A KR 850006051A KR 920009735 B1 KR920009735 B1 KR 920009735B1
Authority
KR
South Korea
Prior art keywords
hsv
wax
gel
cellulose
crosslinked
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
KR1019850006051A
Other languages
English (en)
Korean (ko)
Other versions
KR870001837A (ko
Inventor
요오이치로오 기노
히로시 미조까미
데츠오 가와하라
Original Assignee
자이단호오진 카가구오요비겟세이리요 호오켄키유쇼
노나까 사네오
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 자이단호오진 카가구오요비겟세이리요 호오켄키유쇼, 노나까 사네오 filed Critical 자이단호오진 카가구오요비겟세이리요 호오켄키유쇼
Publication of KR870001837A publication Critical patent/KR870001837A/ko
Application granted granted Critical
Publication of KR920009735B1 publication Critical patent/KR920009735B1/ko
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/245—Herpetoviridae, e.g. herpes simplex virus
    • A61K39/25—Varicella-zoster virus
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/245—Herpetoviridae, e.g. herpes simplex virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16611—Simplexvirus, e.g. human herpesvirus 1, 2
    • C12N2710/16622—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/82—Proteins from microorganisms
    • Y10S530/826—Viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Genetics & Genomics (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
KR1019850006051A 1984-08-24 1985-08-22 단순 헤르페스 바이러스 서브유니트 왁진의 제조방법 Expired KR920009735B1 (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP59177194A JPS6153226A (ja) 1984-08-24 1984-08-24 単純ヘルペスサブユニツトワクチンの精製方法
JP177194 1984-08-24
JP59-177194 1984-08-24

Publications (2)

Publication Number Publication Date
KR870001837A KR870001837A (ko) 1987-03-28
KR920009735B1 true KR920009735B1 (ko) 1992-10-22

Family

ID=16026819

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019850006051A Expired KR920009735B1 (ko) 1984-08-24 1985-08-22 단순 헤르페스 바이러스 서브유니트 왁진의 제조방법

Country Status (7)

Country Link
US (1) US4724146A (enExample)
EP (1) EP0173268B1 (enExample)
JP (1) JPS6153226A (enExample)
KR (1) KR920009735B1 (enExample)
AT (1) ATE54415T1 (enExample)
CA (1) CA1251401A (enExample)
DE (1) DE3578617D1 (enExample)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5244792A (en) * 1984-04-06 1993-09-14 Chiron Corporation Expression of recombinant glyoprotein B from herpes simplex virus
US5171568A (en) * 1984-04-06 1992-12-15 Chiron Corporation Recombinant herpes simplex gb-gd vaccine
US5612041A (en) * 1984-07-17 1997-03-18 Chiron Corporation Recombinant herpes simplex gD vaccine
US5151267A (en) * 1988-07-15 1992-09-29 University Of Saskatchewan Bovine herpesvirus type 1 polypeptides and vaccines
US5585264A (en) * 1988-07-15 1996-12-17 University Of Saskatchewan Nucleotide sequences encoding recombinant bovine herpesvirus type-1 GI, GIII and GIV polypeptides
AU1052492A (en) * 1991-01-31 1992-08-06 Farmitalia Carlo Erba S.R.L. Synergistic composition comprising a fibroblast growth factor and a sulfated polylsaccharide, for use as antiviral agent
US5447859A (en) * 1993-07-16 1995-09-05 Viagene Method for the purification or removal of retroviruses using sulfated cellulose
GB9804632D0 (en) * 1998-03-05 1998-04-29 Cantab Pharma Res Virus preparations and methods
AU2002302069B2 (en) * 1998-03-05 2007-11-15 Cantab Pharmaceuticals Research Limited Virus preparations and methods
US6342384B1 (en) * 1998-08-21 2002-01-29 The University Of Va Patent Foundation Production of adenoviral vectors using serum-free suspension cell culture in a hollow fiber system
EP1361889A1 (en) * 2001-02-23 2003-11-19 GlaxoSmithKline Biologicals S.A. Novel vaccine
DK1361890T3 (da) 2001-02-23 2011-06-27 Glaxosmithkline Biolog Sa Influenzavaccineformuleringer til intradermal indgift
WO2002087494A2 (en) * 2001-04-27 2002-11-07 Glaxosmithkline Biologicals, Sa Novel vaccine
US20070236809A1 (en) 2006-04-05 2007-10-11 Barret Lippey Forming spectral filters
US7959295B2 (en) 2007-05-18 2011-06-14 Dolby Laboratories Licensing Corporation Spectral separation filters for 3D stereoscopic D-cinema presentation
TWI402606B (zh) 2007-05-09 2013-07-21 Dolby Lab Licensing Corp 三維影像之投影與觀看系統
US7784938B2 (en) 2007-05-09 2010-08-31 Dolby Laboratories Licensing Corporation Method and system for shaped glasses and viewing 3D images
DE102013017014B4 (de) 2013-10-14 2017-03-30 Sartorius Stedim Biotech Gmbh Sulfatierte Cellulosehydrat-Membran, Verfahren zur ihrer Herstellung und Verwendung der Membran als Adsorptionsmembran für die Virenaufreinigung
US10809543B2 (en) 2017-01-23 2020-10-20 Dolby Laboratories Licensing Corporation Glasses for spectral and 3D imaging
CN111896731B (zh) * 2020-06-24 2023-06-09 宁波瑞源生物科技有限公司 一种化学发光免疫分析用清洗液

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3920625A (en) * 1973-06-19 1975-11-18 Kabi Ab Isolation of coagulation factors from biological material using cross linked sulfated, sulfonated carbohydrates
SE420977B (sv) * 1976-03-18 1981-11-16 Kabi Ab Forfarande for rening och isolering av hepatitvirus for vaccinframstellning
FI66020C (fi) * 1977-09-19 1984-08-10 Merck & Co Inc Foerfarande foer framstaellning av antigeniska immunogeniska subunits av hsv-1 och hsv-2
US4452734A (en) * 1980-02-11 1984-06-05 Merck & Co., Inc. Herpes subunit vaccine
US4317811A (en) * 1980-09-11 1982-03-02 Merck & Co., Inc. Herpes simplex type 1 subunit vaccine
US4762708A (en) * 1982-02-18 1988-08-09 University Patents, Inc. Materials and methods for herpes simplex virus vaccination
DE3228501A1 (de) * 1982-07-30 1984-02-02 Behringwerke Ag, 3550 Marburg Verfahren zur herstellung eines herpes-antigens, dazu geeignetes mittel sowie verfahren zu seiner herstellung und die verwendung dieses antigens
US4515714A (en) * 1983-03-09 1985-05-07 Juridicial Foundation, The Chemo-Semo-Sero-Therapeutic Research Institute Method for purification of hepatitis B virus surface antigen

Also Published As

Publication number Publication date
JPH0463863B2 (enExample) 1992-10-13
DE3578617D1 (de) 1990-08-16
JPS6153226A (ja) 1986-03-17
EP0173268A3 (en) 1986-05-28
KR870001837A (ko) 1987-03-28
ATE54415T1 (de) 1990-07-15
CA1251401A (en) 1989-03-21
US4724146A (en) 1988-02-09
EP0173268A2 (en) 1986-03-05
EP0173268B1 (en) 1990-07-11

Similar Documents

Publication Publication Date Title
KR920009735B1 (ko) 단순 헤르페스 바이러스 서브유니트 왁진의 제조방법
Frasch et al. An outer membrane protein of Neisseria meningitidis group B responsible for serotype specificity
JP4685238B2 (ja) 静脈投与用免疫グロブリン及び他の免疫グロブリン生成物の製造法
Luka et al. Purification of the Epstein-Barr virus-determined nuclear antigen from Epstein-Barr virus-transformed human lymphoid cell lines
US4724210A (en) Method for purification of influenza virus
Allison et al. Biologic and chemical characterization of HLA antigens in human serum
KR910005889B1 (ko) 단순 헤르페스 바이러스 서브유니트 왁진(Herpes Simplex Virus Subunit Vaccine)의 제조방법
JP2011102314A (ja) 静脈投与用免疫グロブリン及び他の免疫グロブリン生成物の製造法
Schäfer et al. Polypeptides of mammalian oncornaviruses: II. Characterization of a murine leukemia virus polypeptide (p15) bearing interspecies reactivity
EP0118885B1 (en) Method for purification of hepatitis b virus surface antigen
Matsuura et al. Isolation and Characterization of 1, 200 kDa Peptide of α-Connectin
US4164565A (en) Vaccine for active immunization containing hepatitis B surface antigen and associated antigen
JPH0625069B2 (ja) Ｂ型肝炎ワクチン製造方法
US5304636A (en) Receptor for the human rhinovirus minor group
CA1066190A (en) Vaccine for active immunization containing hepatitis b surface antigen and associated antigen
JP3713277B2 (ja) 精製方法
JPS5967226A (ja) ウイルス感染処置に使用する転移因子
Stannard et al. An Fc receptor for human immunoglobulin G is located within the tegument of human cytomegalovirus
US5603932A (en) Receptor of the minor human rhinovirus receptor group
Wyn-Jones et al. Induction of virus-neutralizing antibody by glycoproteins isolated from chicken cells infected with a herpesvirus of turkeys
Kongsvik et al. Capsid components of the parvovirus H-1
Dowdle et al. Production and evaluation of a purified adenovirus group-specific (hexon) antigen for use in the diagnostic complement fixation test
Howard et al. Hepatitis B surface antigen polypeptide micelles from antigen expressed in Saccharomyces cerevisiae
Vasconcelos-Costa Solubilization and purification of surface antigen of cells transformed by adenovirus type 12
KR100258238B1 (ko) 대한민국형 씨(c)형 간염 바이러스의 특이항원인 외피 2씨(c) 단백질의 정제방법

Legal Events

Date Code Title Description
PA0109 Patent application

Patent event code: PA01091R01D

Comment text: Patent Application

Patent event date: 19850822

PG1501 Laying open of application
A201 Request for examination
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 19900703

Comment text: Request for Examination of Application

Patent event code: PA02011R01I

Patent event date: 19850822

Comment text: Patent Application

G160 Decision to publish patent application
PG1605 Publication of application before grant of patent

Comment text: Decision on Publication of Application

Patent event code: PG16051S01I

Patent event date: 19920930

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

Patent event code: PE07011S01D

Comment text: Decision to Grant Registration

Patent event date: 19930119

GRNT Written decision to grant
PR0701 Registration of establishment

Comment text: Registration of Establishment

Patent event date: 19930325

Patent event code: PR07011E01D

PR1002 Payment of registration fee

Payment date: 19930325

End annual number: 3

Start annual number: 1

PR1001 Payment of annual fee

Payment date: 19951021

Start annual number: 4

End annual number: 4

PR1001 Payment of annual fee

Payment date: 19961021

Start annual number: 5

End annual number: 5

PR1001 Payment of annual fee

Payment date: 19970826

Start annual number: 6

End annual number: 6

PR1001 Payment of annual fee

Payment date: 19980508

Start annual number: 7

End annual number: 7

PR1001 Payment of annual fee

Payment date: 19990707

Start annual number: 8

End annual number: 8

PR1001 Payment of annual fee

Payment date: 20000713

Start annual number: 9

End annual number: 9

PR1001 Payment of annual fee

Payment date: 20010612

Start annual number: 10

End annual number: 10

PR1001 Payment of annual fee

Payment date: 20020709

Start annual number: 11

End annual number: 11

PR1001 Payment of annual fee

Payment date: 20030612

Start annual number: 12

End annual number: 12

FPAY Annual fee payment

Payment date: 20040629

Year of fee payment: 13

PR1001 Payment of annual fee

Payment date: 20040629

Start annual number: 13

End annual number: 13

EXPY Expiration of term
PC1801 Expiration of term